Cargando…
Novel Health Information Technology Tool Use by Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: Longitudinal Quantitative and Qualitative Patient-Reported Outcomes
PURPOSE: Health information technology (IT) is an ideal medium to improve the delivery of patient-centered care and increase patient engagement. Health IT interventions should be designed with the end user in mind and be specific to the needs of a given population. Hematopoietic cell transplantation...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873938/ https://www.ncbi.nlm.nih.gov/pubmed/30652535 http://dx.doi.org/10.1200/CCI.17.00110 |
_version_ | 1783472753656987648 |
---|---|
author | Runaas, Lyndsey Hoodin, Flora Munaco, Anna Fauer, Alex Sankaran, Roshun Churay, Tracey Mohammed, Saara Seyedsalehi, Sajjad Chappell, Grant Carlozzi, Noelle Fetters, Michael D. Kentor, Rachel McDiarmid, Leah Brookshire, Kristina Warfield, Casiana Byrd, Michelle Kaziunas, Sharon Maher, Molly Magenau, John An, Larry Cohn, Amy Hanauer, David A. Choi, Sung Won |
author_facet | Runaas, Lyndsey Hoodin, Flora Munaco, Anna Fauer, Alex Sankaran, Roshun Churay, Tracey Mohammed, Saara Seyedsalehi, Sajjad Chappell, Grant Carlozzi, Noelle Fetters, Michael D. Kentor, Rachel McDiarmid, Leah Brookshire, Kristina Warfield, Casiana Byrd, Michelle Kaziunas, Sharon Maher, Molly Magenau, John An, Larry Cohn, Amy Hanauer, David A. Choi, Sung Won |
author_sort | Runaas, Lyndsey |
collection | PubMed |
description | PURPOSE: Health information technology (IT) is an ideal medium to improve the delivery of patient-centered care and increase patient engagement. Health IT interventions should be designed with the end user in mind and be specific to the needs of a given population. Hematopoietic cell transplantation (HCT), commonly referred to as blood and marrow transplantation (BMT), is a prime example of a complex medical procedure where patient-caregiver-provider engagement is central to a safe and successful outcome. We have previously reported on the design and development of an HCT-specific health IT tool, BMT Roadmap. METHODS: This study highlights longitudinal quantitative and qualitative patient-reported outcomes (PROs) in 20 adult patients undergoing allogeneic HCT. Patients completed PROs at three time points (baseline, day 30 post-HTC, and day 100 post-HCT) and provided weekly qualitative data through semistructured interviews while using BMT Roadmap. RESULTS: The mean hospital stay was 23.3 days (range, 17 to 37 days), and patients had access to BMT Roadmap for a mean of 21.3 days (range, 15 to 37 days). The total time spent on BMT Roadmap ranged from 0 to 139 minutes per patient, with a mean of 55 minutes (standard deviation, 47.6 minutes). We found that patients readily engaged with the tool and completed qualitative interviews and quantitative PROs. The Patient Activation Measure, a validated measure of patient engagement, increased for patients from baseline to discharge and day 100. Activation was significantly and negatively correlated with depression and anxiety PROs at discharge, suggesting that this may be an important time point for intervention. CONCLUSION: Given the feasibility and promising results reported in this study, next steps include expanding our current health IT platform and implementing a randomized trial to assess the impact of BMT Roadmap on critical PROs. |
format | Online Article Text |
id | pubmed-6873938 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | American Society of Clinical Oncology |
record_format | MEDLINE/PubMed |
spelling | pubmed-68739382019-12-03 Novel Health Information Technology Tool Use by Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: Longitudinal Quantitative and Qualitative Patient-Reported Outcomes Runaas, Lyndsey Hoodin, Flora Munaco, Anna Fauer, Alex Sankaran, Roshun Churay, Tracey Mohammed, Saara Seyedsalehi, Sajjad Chappell, Grant Carlozzi, Noelle Fetters, Michael D. Kentor, Rachel McDiarmid, Leah Brookshire, Kristina Warfield, Casiana Byrd, Michelle Kaziunas, Sharon Maher, Molly Magenau, John An, Larry Cohn, Amy Hanauer, David A. Choi, Sung Won JCO Clin Cancer Inform Original Reports PURPOSE: Health information technology (IT) is an ideal medium to improve the delivery of patient-centered care and increase patient engagement. Health IT interventions should be designed with the end user in mind and be specific to the needs of a given population. Hematopoietic cell transplantation (HCT), commonly referred to as blood and marrow transplantation (BMT), is a prime example of a complex medical procedure where patient-caregiver-provider engagement is central to a safe and successful outcome. We have previously reported on the design and development of an HCT-specific health IT tool, BMT Roadmap. METHODS: This study highlights longitudinal quantitative and qualitative patient-reported outcomes (PROs) in 20 adult patients undergoing allogeneic HCT. Patients completed PROs at three time points (baseline, day 30 post-HTC, and day 100 post-HCT) and provided weekly qualitative data through semistructured interviews while using BMT Roadmap. RESULTS: The mean hospital stay was 23.3 days (range, 17 to 37 days), and patients had access to BMT Roadmap for a mean of 21.3 days (range, 15 to 37 days). The total time spent on BMT Roadmap ranged from 0 to 139 minutes per patient, with a mean of 55 minutes (standard deviation, 47.6 minutes). We found that patients readily engaged with the tool and completed qualitative interviews and quantitative PROs. The Patient Activation Measure, a validated measure of patient engagement, increased for patients from baseline to discharge and day 100. Activation was significantly and negatively correlated with depression and anxiety PROs at discharge, suggesting that this may be an important time point for intervention. CONCLUSION: Given the feasibility and promising results reported in this study, next steps include expanding our current health IT platform and implementing a randomized trial to assess the impact of BMT Roadmap on critical PROs. American Society of Clinical Oncology 2018-01-11 /pmc/articles/PMC6873938/ /pubmed/30652535 http://dx.doi.org/10.1200/CCI.17.00110 Text en © 2018 by American Society of Clinical Oncology http://creativecommons.org/licenses/by/4.0/ Licensed under the Creative Commons Attribution 4.0 License: http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Original Reports Runaas, Lyndsey Hoodin, Flora Munaco, Anna Fauer, Alex Sankaran, Roshun Churay, Tracey Mohammed, Saara Seyedsalehi, Sajjad Chappell, Grant Carlozzi, Noelle Fetters, Michael D. Kentor, Rachel McDiarmid, Leah Brookshire, Kristina Warfield, Casiana Byrd, Michelle Kaziunas, Sharon Maher, Molly Magenau, John An, Larry Cohn, Amy Hanauer, David A. Choi, Sung Won Novel Health Information Technology Tool Use by Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: Longitudinal Quantitative and Qualitative Patient-Reported Outcomes |
title | Novel Health Information Technology Tool Use by Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: Longitudinal Quantitative and Qualitative Patient-Reported Outcomes |
title_full | Novel Health Information Technology Tool Use by Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: Longitudinal Quantitative and Qualitative Patient-Reported Outcomes |
title_fullStr | Novel Health Information Technology Tool Use by Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: Longitudinal Quantitative and Qualitative Patient-Reported Outcomes |
title_full_unstemmed | Novel Health Information Technology Tool Use by Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: Longitudinal Quantitative and Qualitative Patient-Reported Outcomes |
title_short | Novel Health Information Technology Tool Use by Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: Longitudinal Quantitative and Qualitative Patient-Reported Outcomes |
title_sort | novel health information technology tool use by adult patients undergoing allogeneic hematopoietic cell transplantation: longitudinal quantitative and qualitative patient-reported outcomes |
topic | Original Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873938/ https://www.ncbi.nlm.nih.gov/pubmed/30652535 http://dx.doi.org/10.1200/CCI.17.00110 |
work_keys_str_mv | AT runaaslyndsey novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes AT hoodinflora novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes AT munacoanna novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes AT faueralex novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes AT sankaranroshun novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes AT churaytracey novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes AT mohammedsaara novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes AT seyedsalehisajjad novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes AT chappellgrant novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes AT carlozzinoelle novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes AT fettersmichaeld novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes AT kentorrachel novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes AT mcdiarmidleah novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes AT brookshirekristina novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes AT warfieldcasiana novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes AT byrdmichelle novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes AT kaziunassharon novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes AT mahermolly novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes AT magenaujohn novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes AT anlarry novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes AT cohnamy novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes AT hanauerdavida novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes AT choisungwon novelhealthinformationtechnologytoolusebyadultpatientsundergoingallogeneichematopoieticcelltransplantationlongitudinalquantitativeandqualitativepatientreportedoutcomes |